Related Experiment Videos
Novel halogenated dihydropyridine derivatives with high vascular selectivity
1Pharmakologisches Institut, Universität zu Köln, Federal Republic of Germany.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|October 1, 1988
Summary
Novel halogenated dihydropyridines show improved vascular selectivity, acting as potent vasodilators with weaker negative inotropic effects. Lipophilicity influences their biological activity differently across tissues.
Area of Science:
- Pharmacology
- Medicinal Chemistry
Background:
- Dihydropyridine calcium channel blockers are known for their vasodilator properties.
- Vascular selectivity is crucial for developing effective cardiovascular drugs.
- The influence of steric modifications and physicochemical properties on dihydropyridine activity requires further investigation.
Purpose of the Study:
- To investigate the vascular selectivity of novel halogenated dihydropyridines.
- To examine the relationship between drug structure, lipophilicity, and physiological effects (contractility and vasodilation).
- To determine if structural modifications can enhance vascular selectivity.
Main Methods:
- Synthesis of novel halogenated dihydropyridine derivatives.
- Assessment of negative inotropic effects using isolated guinea pig papillary muscles.
- Evaluation of vasodilator properties in isolated rabbit femoral arteries.
- Measurement of drug lipophilicity.
Main Results:
- All synthesized derivatives displayed dose-dependent negative inotropic and vasodilator effects.
- Halogenated derivatives showed weaker negative inotropic potency than nitrendipine.
- Ester-substituted derivatives exhibited slightly increased vasodilator potency, while halogenation at positions 2 and 6 decreased it.
- Ester-substituted derivatives demonstrated significantly higher vascular selectivity (9-11 times) compared to nitrendipine.
- Lipophilicity correlated with activity: decreased lipophilicity increased activity, except for ester-halogenated derivatives where increased lipophilicity enhanced vasodilation.
Conclusions:
- Novel halogenated dihydropyridines possess improved vascular selectivity due to differential effects on cardiac and vascular smooth muscle.
- Lipophilicity plays a key role in modulating the biological activity and selectivity of these compounds.
- Structural modifications, particularly ester substitution and halogenation, can be strategically employed to enhance the therapeutic profile of dihydropyridine calcium channel blockers.